UiPath Inc. (NYSE: PATH) saw its shares ease by 1.0% on Friday, closing at $18.15, as options traders positioned for a significant price move following the company's upcoming earnings report. With 53.1 million shares changing hands, the market's attention is firmly fixed on the September 3 release, where implied volatility suggests an 11% swing—translating to a potential $2.00 per share move in either direction.
The options market's expectation of an 11% post-earnings move underscores the uncertainty surrounding UiPath's growth trajectory. Based on the company's $9.58 billion market capitalization, this implies roughly $1.05 billion in equity value is at stake, according to options data. The implied range of $16.15 to $20.15 highlights the binary nature of the upcoming report.
UiPath's first-quarter results, reported earlier this year, showed revenue of $418 million, a 17% increase year-over-year, surpassing initial forecasts. However, the company's guidance for the second quarter—projecting revenue between $395 million and $400 million—signals a deceleration, with the midpoint indicating approximately 10% growth. This slowdown comes even as demand for agentic automation solutions, a key growth area for the company, continues to rise.
Annual recurring revenue (ARR), a critical metric for software companies, climbed 12% to $1.901 billion in April, with net new ARR of $49 million. Dollar-based net retention improved to 109%, up from 107% at the end of the previous year. Management noted that agentic products are transitioning from pilot phases to full production, a positive sign for future adoption, but the market is looking for tangible evidence of accelerating recurring revenue.
Financially, UiPath posted its first profitable quarter on a GAAP basis, recording $28 million in operating income. The company generated $132 million in operating cash flow and $130 million in adjusted free cash flow, underpinning its balance sheet strength. With $1.42 billion in cash and marketable securities, UiPath has ample liquidity, but valuation remains a concern. Shares are trading at 30.3 times trailing earnings, a premium that leaves little room for disappointment.
Wall Street's analyst targets, ranging from $12 to $17, sit below the current trading price, underscoring the market's elevated expectations. The upcoming earnings report will be a critical test, as the company needs to demonstrate faster recurring revenue growth and successful agentic-AI adoption beyond just product announcements.
Friday's trading saw shares fluctuate between $18.02 and $18.49, closing near the lower end, reflecting cautious sentiment. The company's full-year revenue forecast of $1.776 billion to $1.781 billion, along with an ARR projection of $2.058 billion to $2.063 billion by January, will be closely scrutinized against actual performance.
Risks remain, including potential slowdowns in enterprise agreements, soft public sector demand, and competition from Microsoft, ServiceNow, and AI-focused products. The market's reaction to the earnings release will hinge on whether UiPath can deliver the growth acceleration that its valuation demands.
